Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases

Jose Camargo Galvis, P. A. Correa, J. Castiblanco, J. M. Anaya

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Interleukin-1 beta (IL-1β) exerts a range of inflammatory and immunomodulatory activities that are important in host defense and autoimmune response. The IL-1β gene, located on chromosome 2 (2q13), is polymorphic. The influence of its polymorphism on 355 patients with autoimmune rheumatic diseases was examined. To this effect, 172 patients with rheumatoid arthritis (RA), 114 with systemic lupus erythematosus (SLE), and 69 with primary Sjögren's syndrome (pSS) were studied. The control group consisted of 392 matched healthy individuals. Genotyping of IL-1β single-nucleotide polymorphisms (SNPs) at positions -511 (C/T) and + 3953 (C/T) was performed by the polymerase chain reaction-restriction fragment length polymorphism technique. In addition, levels of IL-1β were measured by immunoassay in supernatants of lipopolysaccharide (LPS)-stimulated and nonstimulated peripheral blood monocytes (PBM) obtained from 19 homozygous individuals for the three most common IL-1β likely haplotypes, all belonging to the control group. Allele + 3953T was protective for SLE (odds ratio (OR = 0.57, 95% confidence intervals (CI) = 0.34-0.88, P = 0.01) as was the haplotype -511C + 3953T (OR = 0.43, 95%CI = 0.25-0.74, pc = 0.006). The latter was associated with a lower LPS-stimulated-PBM IL-1β secretion. Results suggest that IL-1β polymorphism influences the susceptibility to acquire SLE in our population. The protective association might be explained by the observed inhibitory effect of IL-1β + 3953T allele on the secretion of IL-1β under inflammatory circumstances.

Original languageEnglish (US)
Pages (from-to)609-614
Number of pages6
JournalGenes and Immunity
Volume5
Issue number8
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Rheumatic Diseases
Interleukin-1beta
Interleukin-1
Autoimmune Diseases
Systemic Lupus Erythematosus
Haplotypes
Lipopolysaccharides
Monocytes
Alleles
Confidence Intervals
Control Groups
Chromosomes, Human, Pair 2
Autoimmunity
Immunoassay
Restriction Fragment Length Polymorphisms
Single Nucleotide Polymorphism
Rheumatoid Arthritis
Odds Ratio
Polymerase Chain Reaction
Population

Keywords

  • Interleukin-1 beta
  • Polymorphisms
  • Rheumatoid arthritis
  • Sjögren's syndrome
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases. / Camargo Galvis, Jose; Correa, P. A.; Castiblanco, J.; Anaya, J. M.

In: Genes and Immunity, Vol. 5, No. 8, 12.2004, p. 609-614.

Research output: Contribution to journalArticle

Camargo Galvis, Jose ; Correa, P. A. ; Castiblanco, J. ; Anaya, J. M. / Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases. In: Genes and Immunity. 2004 ; Vol. 5, No. 8. pp. 609-614.
@article{0d7fe1f360ba45a485c5dd2e1c036b42,
title = "Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases",
abstract = "Interleukin-1 beta (IL-1β) exerts a range of inflammatory and immunomodulatory activities that are important in host defense and autoimmune response. The IL-1β gene, located on chromosome 2 (2q13), is polymorphic. The influence of its polymorphism on 355 patients with autoimmune rheumatic diseases was examined. To this effect, 172 patients with rheumatoid arthritis (RA), 114 with systemic lupus erythematosus (SLE), and 69 with primary Sj{\"o}gren's syndrome (pSS) were studied. The control group consisted of 392 matched healthy individuals. Genotyping of IL-1β single-nucleotide polymorphisms (SNPs) at positions -511 (C/T) and + 3953 (C/T) was performed by the polymerase chain reaction-restriction fragment length polymorphism technique. In addition, levels of IL-1β were measured by immunoassay in supernatants of lipopolysaccharide (LPS)-stimulated and nonstimulated peripheral blood monocytes (PBM) obtained from 19 homozygous individuals for the three most common IL-1β likely haplotypes, all belonging to the control group. Allele + 3953T was protective for SLE (odds ratio (OR = 0.57, 95{\%} confidence intervals (CI) = 0.34-0.88, P = 0.01) as was the haplotype -511C + 3953T (OR = 0.43, 95{\%}CI = 0.25-0.74, pc = 0.006). The latter was associated with a lower LPS-stimulated-PBM IL-1β secretion. Results suggest that IL-1β polymorphism influences the susceptibility to acquire SLE in our population. The protective association might be explained by the observed inhibitory effect of IL-1β + 3953T allele on the secretion of IL-1β under inflammatory circumstances.",
keywords = "Interleukin-1 beta, Polymorphisms, Rheumatoid arthritis, Sj{\"o}gren's syndrome, Systemic lupus erythematosus",
author = "{Camargo Galvis}, Jose and Correa, {P. A.} and J. Castiblanco and Anaya, {J. M.}",
year = "2004",
month = "12",
doi = "10.1038/sj.gene.6364133",
language = "English (US)",
volume = "5",
pages = "609--614",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases

AU - Camargo Galvis, Jose

AU - Correa, P. A.

AU - Castiblanco, J.

AU - Anaya, J. M.

PY - 2004/12

Y1 - 2004/12

N2 - Interleukin-1 beta (IL-1β) exerts a range of inflammatory and immunomodulatory activities that are important in host defense and autoimmune response. The IL-1β gene, located on chromosome 2 (2q13), is polymorphic. The influence of its polymorphism on 355 patients with autoimmune rheumatic diseases was examined. To this effect, 172 patients with rheumatoid arthritis (RA), 114 with systemic lupus erythematosus (SLE), and 69 with primary Sjögren's syndrome (pSS) were studied. The control group consisted of 392 matched healthy individuals. Genotyping of IL-1β single-nucleotide polymorphisms (SNPs) at positions -511 (C/T) and + 3953 (C/T) was performed by the polymerase chain reaction-restriction fragment length polymorphism technique. In addition, levels of IL-1β were measured by immunoassay in supernatants of lipopolysaccharide (LPS)-stimulated and nonstimulated peripheral blood monocytes (PBM) obtained from 19 homozygous individuals for the three most common IL-1β likely haplotypes, all belonging to the control group. Allele + 3953T was protective for SLE (odds ratio (OR = 0.57, 95% confidence intervals (CI) = 0.34-0.88, P = 0.01) as was the haplotype -511C + 3953T (OR = 0.43, 95%CI = 0.25-0.74, pc = 0.006). The latter was associated with a lower LPS-stimulated-PBM IL-1β secretion. Results suggest that IL-1β polymorphism influences the susceptibility to acquire SLE in our population. The protective association might be explained by the observed inhibitory effect of IL-1β + 3953T allele on the secretion of IL-1β under inflammatory circumstances.

AB - Interleukin-1 beta (IL-1β) exerts a range of inflammatory and immunomodulatory activities that are important in host defense and autoimmune response. The IL-1β gene, located on chromosome 2 (2q13), is polymorphic. The influence of its polymorphism on 355 patients with autoimmune rheumatic diseases was examined. To this effect, 172 patients with rheumatoid arthritis (RA), 114 with systemic lupus erythematosus (SLE), and 69 with primary Sjögren's syndrome (pSS) were studied. The control group consisted of 392 matched healthy individuals. Genotyping of IL-1β single-nucleotide polymorphisms (SNPs) at positions -511 (C/T) and + 3953 (C/T) was performed by the polymerase chain reaction-restriction fragment length polymorphism technique. In addition, levels of IL-1β were measured by immunoassay in supernatants of lipopolysaccharide (LPS)-stimulated and nonstimulated peripheral blood monocytes (PBM) obtained from 19 homozygous individuals for the three most common IL-1β likely haplotypes, all belonging to the control group. Allele + 3953T was protective for SLE (odds ratio (OR = 0.57, 95% confidence intervals (CI) = 0.34-0.88, P = 0.01) as was the haplotype -511C + 3953T (OR = 0.43, 95%CI = 0.25-0.74, pc = 0.006). The latter was associated with a lower LPS-stimulated-PBM IL-1β secretion. Results suggest that IL-1β polymorphism influences the susceptibility to acquire SLE in our population. The protective association might be explained by the observed inhibitory effect of IL-1β + 3953T allele on the secretion of IL-1β under inflammatory circumstances.

KW - Interleukin-1 beta

KW - Polymorphisms

KW - Rheumatoid arthritis

KW - Sjögren's syndrome

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=11044228572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11044228572&partnerID=8YFLogxK

U2 - 10.1038/sj.gene.6364133

DO - 10.1038/sj.gene.6364133

M3 - Article

C2 - 15470475

AN - SCOPUS:11044228572

VL - 5

SP - 609

EP - 614

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 8

ER -